What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Osteoporosis
His primary scientific interests are in Osteoporosis, Internal medicine, Bone mineral, Bone density and Surgery.
His Osteoporosis study incorporates themes from Placebo, Physical therapy, Bone remodeling and Urology.
Many of his studies involve connections with topics such as Endocrinology and Internal medicine.
His study in Bone mineral is interdisciplinary in nature, drawing from both Relative risk and Orthopedic surgery.
His biological study spans a wide range of topics, including Teriparatide, Radiology and Densitometry.
In his study, Postmenopausal women is inextricably linked to Intensive care medicine, which falls within the broad field of Surgery.
His most cited work include:
- Primer on the metabolic bone diseases and disorders of mineral metabolism (1854 citations)
- Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial. (412 citations)
- Antifracture Efficacy of Antiresorptive Agents Are Related to Changes in Bone Density (362 citations)
What are the main themes of his work throughout his whole career to date?
Paul D. Miller focuses on Osteoporosis, Internal medicine, Bone mineral, Surgery and Bone density.
Paul D. Miller interconnects Placebo, Physical therapy, Bone remodeling and Urology in the investigation of issues within Osteoporosis.
He focuses mostly in the field of Internal medicine, narrowing it down to matters related to Endocrinology and, in some cases, Parathyroid hormone.
His Bone mineral research focuses on Densitometry and how it relates to Bone mass.
The concepts of his Surgery study are interwoven with issues in Tolerability, Adverse effect, Ibandronic acid and Bone disease.
His Bone density study incorporates themes from Radiology, MEDLINE and Family medicine.
He most often published in these fields:
- Osteoporosis (63.61%)
- Internal medicine (43.04%)
- Bone mineral (28.16%)
What were the highlights of his more recent work (between 2015-2021)?
- Osteoporosis (63.61%)
- Internal medicine (43.04%)
- Abaloparatide (6.01%)
In recent papers he was focusing on the following fields of study:
Paul D. Miller mainly investigates Osteoporosis, Internal medicine, Abaloparatide, Bone mineral and Urology.
His work on Osteoporosis is being expanded to include thematically relevant topics such as Placebo.
Paul D. Miller works mostly in the field of Internal medicine, limiting it down to topics relating to Endocrinology and, in certain cases, Parathyroid hormone.
His Bone mineral research includes themes of Height loss and Lumbar spine, Surgery.
His Surgery research incorporates elements of Bisphosphonate and MEDLINE.
His Urology research includes elements of Anabolism and Bone regeneration.
Between 2015 and 2021, his most popular works were:
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial (339 citations)
- Paracetamol: not as safe as we thought? A systematic literature review of observational studies (204 citations)
- Vertebral Fractures: Clinical Importance and Management (114 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Osteoporosis
Osteoporosis, Teriparatide, Internal medicine, Surgery and Placebo are his primary areas of study.
Paul D. Miller works mostly in the field of Osteoporosis, limiting it down to topics relating to Urology and, in certain cases, Denosumab, as a part of the same area of interest.
Paul D. Miller has included themes like Cortical bone, Biopsy and Bone formation in his Teriparatide study.
His research on Internal medicine often connects related areas such as Endocrinology.
His Surgery research is multidisciplinary, relying on both Bisphosphonate, Cohort study and MEDLINE.
Paul D. Miller usually deals with Placebo and limits it to topics linked to Postmenopausal osteoporosis and Drug Substitution and Phases of clinical research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
